FDA recall D-0024-2017

Teva Pharmaceuticals USA · Class II · drug

Product

Amikacin Sulfate Injection, USP, 1 gm/4 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-9040-01 (individual pack), NDC 0703-9040-03 (shelf-pack carton of 10 vials).

Reason for recall

CGMP Deviations

Distribution

Nationwide and Puerto Rico

Key facts

Status
Terminated
Initiation date
2016-07-29
Report date
2016-10-19
Termination date
2018-02-05
Voluntary/Mandated
Voluntary: Firm initiated
Location
North Wales, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0024-2017